Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, April 20, 2021
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
[ Tue, Apr 20th 2021
] - WOPRAI
Mon, April 19, 2021
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
[ Mon, Apr 19th 2021
] - WOPRAI
Jeffrey Hung Maintained (VYGR) at Hold with Decreased Target to $6 on, Apr 19th, 2021
Jeffrey Hung of Morgan Stanley, Maintained "Voyager Therapeutics, Inc." (VYGR) at Hold with Decreased Target from $7 to $6 on, Apr 19th, 2021.
Jeffrey has made no other calls on VYGR in the last 4 months.
There are 3 other peers that have a rating on VYGR. Out of the 3 peers that are also analyzing VYGR, all agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Skorney of "Baird" Downgraded from Buy to Hold and Decreased Target to $6 on, Friday, February 26th, 2021
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Decreased Target to $6 on, Wednesday, February 3rd, 2021
- Thomas Shrader of "BTIG" Downgraded from Strong Buy to Hold on, Wednesday, February 3rd, 2021
